SKI Market

Indian Indices

Nifty

22,055.20 97.70
(0.44%)

Sensex

72,664.47 260.30
( 0.36%)

Bank Nifty

47,421.10 -66.80
( -0.14%)

Nifty IT

32,935.15 -270.70
( -0.82%)

Global Indices

Nasdaq

16,340.87 -5.39
(-0.03%)

Dow Jones

39,512.84 125.08
(0.32%)

Hang Seng

18,963.68 425.87
(2.30%)

Nikkei 225

38,229.11 155.13
(0.41%)

Forex

USD-INR

83.52 0.04
(0.05%)

EUR-INR

89.99 0.20
(0.22%)

GBP-INR

104.60 0.26
(0.25%)

JPY-INR

0.54 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Zim Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

541400

INE518E01015

45.0243097

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ZIMLAB

35.08

560.59

EPS(TTM)

Face Value()

Div & Yield %

3.28

Back

balaxi pharmaceuticals ltd

Balaxi Pharmaceuticals consolidated net profit rises 65.13% in the December 2023 quarter

Feb 09,2024

Net profit of Balaxi Pharmaceuticals rose 65.13% to Rs 13.59 crore in the quarter ended December 2023 as against Rs 8.23 crore during the previous quarter ended December 2022. Sales declined 29.79% to Rs 60.79 crore in the quarter ended December 2023 as against Rs 86.58 crore during the previous quarter ended December 2022.

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	60.79	86.58	-30
OPM %	22.47	17.67	-
PBDT	13.11	10.71	22
PBT	12.63	10.53	20
NP	13.59	8.23	65

22,055.20 97.70 (0.44%)

72,664.47 260.30 ( 0.36%)

47,421.10 -66.80 ( -0.14%)

32,935.15 -270.70 ( -0.82%)

16,340.87 -5.39 (-0.03%)

39,512.84 125.08 (0.32%)

18,963.68 425.87 (2.30%)

38,229.11 155.13 (0.41%)

83.52 0.04 (0.05%)

89.99 0.20 (0.22%)

104.60 0.26 (0.25%)

0.54 0.00 (-0.02%)